A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

PHASE2CompletedINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

August 3, 2009

Primary Completion Date

February 18, 2010

Study Completion Date

February 18, 2010

Conditions

Dry Eye

Interventions

DRUG

Lifitegrast

Ophthalmic Solution

DRUG

Placebo

Ophthalmic Solution

Trial Locations (5)

Mundorf Eye Center, Charlotte

Total Eye Care, P.A., Memphis

The Eye Care Group, Waterbury

Central Maine Eye Care, Lewiston

Ora, Inc. (two locations), Andover